An error occurred retrieving content to display, please try again.
Home >> Journals >> Efficacy and Mechanism Evaluation >> Page Not FoundPlease choose a page from the navigation or try a website search above to find the information you need.
In this single-centre trial of 62 patients, omalizumab led to some improvements in eczema severity that, although on average relatively small, may be clinically important for some patients.
{{author}}{{author}}{{($index < metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}
Susan MH Chan
[Image - ORCID logo], Suzie Cro
[Image - ORCID logo], Victoria Cornelius
[Image - ORCID logo], Rahi Jahan
[Image - ORCID logo], Suzana Radulovic
[Image - ORCID logo] & Gideon Lack.
Susan MH Chan 1,2,*, Suzie Cro 3, Victoria Cornelius 3, Rahi Jahan 4, Suzana Radulovic 1,2, Gideon Lack 2
1 Guy’s and St Thomas’ NHS Foundation Trust, London, UK
2 Department of Women and Children’s Health, School of Life Course Sciences and School of Immunology and Microbial Sciences, King’s College London, London, UK
3 Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK
4 The Royal Marsden NHS Foundation Trust, London, UK
* Corresponding author Email: susan.chan@kcl.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation: {{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al.' : ''}} . {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
[Image - Crossmark status check]The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
No responses have been published.
© NIHR 2024